Kelly Norsworthy
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
Kelly Norsworthy
Aug 23, 2024, 06:30 |
Drugs
Taha Al-Juhaishi: Treatment of AML in the community setting
Taha Al-Juhaishi, Associate Director of Hematopoietic Stem Cell Transplantation and Cell Therapy at OU Health…
Jul 30, 2024, 13:23 |
Insight
Treatment of CML in pregnant patients and patients who are breastfeeding
FDA Oncology shared on X: An expert panel convened by FDA provides perspectives on drug…
Jul 15, 2024, 13:21 |
Blog
Talha Badar: CRh as a Palliative Endpoint for Treatment of Acute Myeloid Leukemia
Talha Badar shared on X: "Complete remission with partial hematological recovery as a palliative endpoint for…
Jul 7, 2024, 15:49 |
Blog
Kelly Norsworthy: Submit your Pragmatic Trials ideas to FDA Oncology
Kelly Norsworthy, Deputy Division Director, Division of Hematologic Malignancies 1 at Johns Hopkins University, shared…
May 7, 2024, 15:45 |
Blog
FDA Oncology's Project 5 in 5
Kelly Norsworthy, Deputy Division Director, Division of Hematologic Malignancies 1 at Johns Hopkins University, shared a…
Feb 23, 2024, 11:08 |
Insight
Provides an overview of oncology drugs approved the previous year - Nature Reviews Clinical Oncology
Nature Reviews Clinical Oncology shared a post on X: "One more year FDA Oncology provides an…
All:
6
Posts:
1 - 100
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024
Uniting Forces: Leveraging Cancer Research to Revolutionize Tuberculosis Treatment
World - first lung cancer vaccine trials launched across 7 countries
Lance Armstrong and Testicular Cancer: Story, Symptoms, Treatment
Honoring Jeff Weber, a giant in the field of oncology
Facebook
RSS Feed
Twitter
Linkedin
Youtube